Phibro Animal Health Corporation (PAHC) Stock Forecast
PAHC analyst forecast
as of October 18, 2026- Analyst consensus
- Hold 3.00 / 5 from 4 analysts
- Price target
- $47.00 average of analyst targets
- Upside to target
- +21.1% from the latest close
- Next earnings
- November 4, 2026 EPS estimate $0.77
- 52-week range
- $28.52 – $59.58
PAHC analyst ratings
4 analystsNumber of analysts at each rating.
PAHC price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
PAHC earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.78 | $0.76 | $0.81 | $0.73 | +7.2% | 3 |
| Next quarter (Dec '26) | $0.94 | $0.91 | $0.97 | $0.87 | +8.0% | 2 |
| Current fiscal year (FY2027) | $3.50 | $3.48 | $3.51 | $3.22 | +8.6% | 3 |
| Next fiscal year (FY2028) | $3.85 | $3.68 | $4.10 | $3.50 | +10.1% | 3 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
PAHC revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $383.0M | $383.0M | $383.0M | +5.2% | 1 |
| Next quarter (Dec '26) | $393.0M | $393.0M | $393.0M | +5.1% | 1 |
| Current fiscal year (FY2027) | $1.58B | $1.57B | $1.58B | +3.9% | 3 |
| Next fiscal year (FY2028) | $1.63B | $1.62B | $1.65B | +3.5% | 3 |
PAHC EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
PAHC revenue: reported and forecast
PAHC EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.79 | $0.79 | $0.77 | $0.76 | $0.78 | −0.9% | 0 up · 1 down |
| Next quarter (Dec '26) | $0.91 | $0.91 | $0.97 | $0.99 | $0.94 | +3.3% | 1 up · 0 down |
| Current fiscal year (FY2027) | $3.34 | $3.34 | $3.50 | $3.50 | $3.50 | +4.6% | 5 up · 0 down |
| Next fiscal year (FY2028) | $3.69 | $3.69 | $3.85 | $3.84 | $3.85 | +4.4% | 4 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
PAHC earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; PAHC beat in 11 of 12.
What analysts expect from PAHC
4 analysts cover Phibro Animal Health; their consensus rating is hold (3.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $47.00, 21.1% above the latest close of $38.82. Analysts expect earnings of $3.50 per share for FY2027, +8.6% from a year earlier. For FY2028 the average estimate is $3.85 per share on revenue of $1.6 billion. Phibro Animal Health beat the EPS estimate in 11 of the last 12 quarters.
Related: PAHC income statement, PAHC key metrics, PAHC chart. See the PAHC stock overview for the latest quote and news.
PAHC forecast FAQ
What is Phibro Animal Health's price target?
The average analyst price target for Phibro Animal Health is $47.00, 21.1% above the latest close of $38.82.
Is Phibro Animal Health a buy, hold or sell?
Of 4 analysts covering Phibro Animal Health, 0 rate it a strong buy, 1 a buy, 2 a hold, 1 a sell and 0 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.
What is Phibro Animal Health's EPS forecast?
Analysts forecast $3.50 per share for FY2027 (range $3.48 to $3.51); for FY2028 the estimate is $3.85.
What is Phibro Animal Health's revenue forecast?
The average revenue estimate for FY2027 is $1.6 billion, growth of 3.9%; for FY2028 it is $1.6 billion.
When does Phibro Animal Health report earnings?
Phibro Animal Health is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 after the market closes; the EPS estimate is $0.77.
Does Phibro Animal Health usually beat earnings estimates?
Phibro Animal Health reported EPS at or above the analyst estimate in 11 of the last 12 quarters.